Emsam selegiline regulatory update

FDA accepted from Somerset a response to a January 2004 approvable letter for Emsam selegiline to treat major depressive disorder and issued a PDUFA date of Nov. 27 (see BioCentury, Feb. 9, 2004). Bri...